SerbinCommunications

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbin.com LA / NY / UK

David Bolinsky

OncoSec Immunopulse Immunotherapy Program 

Prev Next
Previous

OncoSec Immunopulse Immunotherapy Program

medical illustration of OncoSec has developed a method for directly stimulating T-cells to aggregate within a tumor, bypassing natural checkpoint inhibition that protects tumors from the immune system. This still from the animation shows the IL-12 molecule coded by the plasmid.
Next medical illustration of OncoSec has developed a method for directly stimulating T-cells to aggregate within a tumor, bypassing natural checkpoint inhibition that protects tumors from the immune system. This still from the animation shows an antibody targeting the a T-cell attaching to a tumor cell that has had its checkpoint inhibition blocked.

OncoSec Immunopulse Immunotherapy Program

OncoSec has developed a method for directly stimulating T-cells to aggregate within a tumor, bypassing natural checkpoint inhibition that protects tumors from the immune system. This still from the animation shows the IL-12 molecule coded by the plasmid.

Keywords: Animation, 3D, Advertising / Marketing, Patient Education, Professional Education, Biotechnology, Cell biology / Histology, Oncology, Mechanism of Action (MOA)

© David Bolinsky